New search | Conferencedetail
mail
Print view
 
 

6th Microbiome Movement - Drug Development Summit Europe

Evvnt Promotion / evvnt
-
25.01.2022 - 27.01.2022  The Tower Hotel, St Katharine's Way, E1W 1LD Greater London, England, United Kingdom
Time: 10:00 to 17:50
 
Conference themes
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/919896-3?pid=4832

Speakers: Charles Bundinof, Strain Discovery and Microbiome Science Lead, IFF, Denise Kelly, Investment Advisor, Seventure, Duncan Peyton, CEO, 4D Pharma PLC, and more.
 

Enquiries and Registration:

https://go.evvnt.com/919896-2?pid=4832
Ms. Emily Lincoln
 
Categories
General Medicine
Languages
English
Congress fees
Drug Developer - Conference Only: GBP 2049.00, Academic - Conference Only: GBP 1649.00, Solution and Service Provider - Conference Only: GBP 2699.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Swiss Tropical and Public Health InstituteCharité International AcademyEuropean Health Forum GasteinÖsterreichisches Rotes KreuzÄrzte der WeltnewTreeÖsterreichische Gesellschaft für Public HealthAnästhesie in Entwicklungsländern e. V.